WIPF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.969000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.324600E-01
Normal-vs-Stage2
7.644000E-01
Normal-vs-Stage3
6.502600E-01
Normal-vs-Stage4
2.184800E-01
Stage1-vs-Stage2
7.233200E-01
Stage1-vs-Stage3
4.734000E-01
Stage1-vs-Stage4
8.414400E-02
Stage2-vs-Stage3
3.685600E-01
Stage2-vs-Stage4
1.040400E-01
Stage3-vs-Stage4
1.226410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.133400E-01
Normal-vs-AfricanAmerican
3.713600E-01
Normal-vs-Asian
6.195200E-01
Caucasian-vs-AfricanAmerican
2.200000E-01
Caucasian-vs-Asian
2.044400E-01
AfricanAmerican-vs-Asian
6.851600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.024800E-01
Normal-vs-Female
8.009200E-01
Male-vs-Female
8.328400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.131000E-01
Normal-vs-Age(41-60Yrs)
3.574200E-01
Normal-vs-Age(61-80Yrs)
9.880000E-01
Normal-vs-Age(81-100Yrs)
6.903800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.754800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.825000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.909400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.743800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.024300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.245400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.164400E-01
Normal-vs-Daily Drinker
7.307800E-01
Normal-vs-Weekly Drinker
9.108600E-01
Normal-vs-Occasional Drinker
3.447400E-01
Normal-vs-Social Drinker
6.587400E-01
Non Drinker-vs-Daily Drinker
4.207200E-01
Non Drinker-vs-Weekly Drinker
7.181800E-01
Non Drinker-vs-Occasional Drinker
2.126400E-01
Non Drinker-vs-Social Drinker
7.960400E-01
Daily Drinker-vs-Weekly Drinker
7.216000E-01
Daily Drinker-vs-Occasional Drinker
1.443890E-02
Daily Drinker-vs-Social Drinker
1.758850E-01
Weekly Drinker-vs-Occasional Drinker
8.026500E-02
Weekly Drinker-vs-Social Drinker
4.232400E-01
Occasional Drinker-vs-Social Drinker
2.069000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.329600E-02
Normal-vs-Grade 2
2.749600E-02
Normal-vs-Grade 3
5.164400E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.609800E-02
Grade 1-vs-Grade 3
4.454400E-02
Grade 1-vs-Grade 4
6.329600E-02
Grade 2-vs-Grade 3
8.332200E-01
Grade 2-vs-Grade 4
2.749600E-02
Grade 3-vs-Grade 4
5.164400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.147200E-01
Normal-vs-NonDiabetic
7.782400E-01
Diabetic-vs-NonDiabetic
1.173830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.994600E-01
Normal-vs-NoPancreatitis
8.712800E-01
Pancreatitis-vs-NoPancreatitis
8.100600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.915600E-01
Normal-vs-N1
7.318200E-01
N0-vs-N1
1.744250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.546000E-01
Normal-vs-TP53-NonMutant
9.294400E-01
TP53-Mutant-vs-TP53-NonMutant
1.261790E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
